Case Control Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 289-300
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.289
Table 5 Haplotype analysis of polymorphisms in patients and controls
SNPsHaplo-typeControl (n = 290, %)NAG (n = 116, %)AG (n = 106, %)IM (n = 366, %)χ2-1P1 valueOR1χ2-2P2 valueOR2χ2-3P3 valueOR3
rs907715| rs12508721CC0.4960.5430.5750.5710.7130.3971.20 (0.78-1.86)1.9360.1641.37 (0.88-2.15)3.6120.0571.35 (1.00-1.84)
CT0.0660.0600.0570.0710.0370.8471.09 (0.45-2.67)0.1040.7471.17 (0.45-3.01)0.0770.7810.92 (0.50-1.69)
TC0.1630.1380.0470.0870.3680.5441.21 (0.66-2.23)8.9840.0033.91 (1.51-10.11)8.5090.0042.02 (1.25-3.26)
TT0.2750.2590.3210.2710.1250.7241.09 (0.67-1.78)0.7630.3820.81 (0.50-1.31)0.0240.8781.03 (0.73-1.45)
rs2221903| rs907715CC0.12801290.1230.1580.0020.9630.99 (0.52-1.87)0.0170.8961.05 (0.53-2.06)1.2640.2640.78 (0.50-1.21)
CT0.0060.0260.0190.0142.4500.1180.26 (0.04-1.59)1.1130.2920.36 (0.05-2.60)0.7010.4040.50 (0.10-2.60)
TC0.4340.4740.5090.4840.5270.4680.85 (0.55-1.31)1.7590.1850.74 (0.47-1.16)1.5710.2100.82 (0.60-1.12)
TT0.4320.3710.3490.3441.2440.2651.29 (0.83-2.00)2.1580.1421.41 (0.89-2.24)5.1570.0231.44 (1.05-1.98)